Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer Meeting Abstract


Authors: Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; Ilson, D.; Kemeny, N. E.; Saltz, L.
Abstract Title: Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
Meeting Title: 2012 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 4 Suppl.
Meeting Dates: 2012 Jan 19-21
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-02-01
Language: English
ACCESSION: WOS:000209849300461
DOI: 10.1200/jco.2012.30.4_suppl.467
PROVIDER: wos
Notes: Meeting Abstract: 467 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    792 Saltz
  2. Marc J Gollub
    209 Gollub
  3. Neil Howard Segal
    210 Segal
  4. Zsofia Kinga Stadler
    394 Stadler
  5. Diane Lauren Reidy
    295 Reidy
  6. Yelena Yuriy Janjigian
    400 Janjigian
  7. Jinru Shia
    720 Shia
  8. David H Ilson
    436 Ilson
  9. Eileen O'Reilly
    790 O'Reilly
  10. Nancy Kemeny
    545 Kemeny